Results 111 to 120 of about 640,779 (308)

Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features. [PDF]

Pathol Oncol Res, 2021
Turkevi-Nagy S, Báthori Á, Böcz J, Krenács L, Cserni G, Kővári B.   +5 more
europepmc   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source

Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology. [PDF]

Int J Endocrinol, 2021
Panagiotou G, Triantafyllidou S, Tarlatzis BC, Papakonstantinou E.   +3 more
europepmc   +1 more source

BREAST TUMOR (PAPILLOMA) IN A PREGNANT WOMAN (CLINICAL CASE)

Мать и дитя в Кузбассе
The weakly positive Rh factor (Du phenotype) was described by The cause of neoplasms is the human papillomavirus (HPV), which infects about 80% of the world's population.
Светлана Ивановна Елгина, Екатерина Владимировна Грищенко, Елена Владимировна Рудаева, Кира Борисовна Мозес, Наталья Степановна Черных   +4 more
doaj  

An investigational protocol of intraoperative radiotherapy in the treatment of early-stage breast cancer: partial results from the Hospital Israelita Albert Einstein [PDF]

Einstein (São Paulo), 2007
Objective: To describe and assess the experience of the HospitalAlbert Einstein on the treatment of early-stage breast cancer withintraoperative radiotherapy. Methods: Twenty-two patients withinvasive breast cancer, older than 45 years, with tumors ≤ 2.5
Silvio Eduardo Bromberg, Maria Augusta Bernardini, Antonio Luis Frasson, Jairo Wagner, Filadelfico Venco, Rodrigo Hanriot, Artur Katz, Sergio Simon   +7 more
doaj  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Breast cancer : what you need to know [PDF]

Cancer is a disease in which cells in the body grow out of control. When cancer starts in the breast, it is called breast cancer. Except for skin cancer, breast cancer is the most common cancer in American women.Breast cancer screening means checking a ...

core  

Breast Cancer Res Treat [PDF]

Objective:The goal of this systematic review is to provide an update to the review by Pouwels et al. by conducting a systematic review and an assessment of the reporting quality of the economic analyses conducted since 2014.Methods:This systematic review

core   +4 more sources

Survey of dentin sialophosphoprotein and its cognate matrix metalloproteinase‐20 in human cancers

Cancer Medicine, 2019
Background Matrix metalloproteinases‐20 (MMP20) expression is widely regarded as tooth specific, with expression limited to dental hard tissues. Recently, we reported MMP20 expression and interaction with dentin sialophosphoprotein (DSPP), a member of ...
Jaya Aseervatham, Saxena Geetu, Charles C. Anunobi, Komal Koli, Kalu U. E. Ogbureke   +4 more
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source